Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Women news

Show

From To
Women’s bacteria thwarted attempt at anti-HIV vaginal gel

Creating new HIV prevention tools for women has proven frustratingly slow and researchers have found another hurdle: bacteria in the reproductive tract.

Published
02 June 2017
From
STAT
HIV status may affect the progression of HPV infection to cervical pre-cancer

HIV-positive women were more likely to have human papillomavirus infection progress to pre-cancerous cervical lesions

Published
02 June 2017
From
Science Daily
Young women in Zimbabwe in sexual relationships with older men have an especially high risk of infection with HIV

Young women in Zimbabwe have an especially high risk of infection with HIV if they have a sexual partner who is ten or more years older, investigators

Published
02 June 2017
By
Michael Carter
Unprecedented extension of Global Gag Rule puts HIV programmes at risk

The Alliance comments: "In implementing this controversial policy, the US government will force organisations to choose between either women’s right to comprehensive health services and advice, or vital support for tens of millions of people living with HIV. This is an impossible dilemma for organisations like ours. We urge the US government to re-evaluate its stance, to ensure that we stay on target to end AIDS by 2030." See also https://www.theguardian.com/global-development/2017/feb/14/bill-and-melinda-gates-trumps-global-gag-rule-endangers-millions-women-girls-us-funding

Published
17 May 2017
From
International HIV/AIDS Alliance
HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients?

This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of daily TDF/FTC before they can consider themselves protected from vaginal HIV exposure -- but the World Health Organization (WHO) has stated that just seven days of the drug is enough.

Published
03 May 2017
From
The Body Pro
Nelly Mugo—rolling out PrEP in Kenya

Nelly Mugo has had a central role in building evidence for PrEP, as a co-author on the Partners PrEP study. Most of her current work is focused on scale-up and roll-out of PrEP.

Published
28 April 2017
From
The Lancet (free registration required)
The living legacy of the Global Plan: eliminating HIV in children

The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

Published
20 April 2017
From
UNAIDS
PrEP should be given to all breastfed babies, researchers say

An international group of researchers involved in the ANRS 12174 randomised controlled trial of pre-exposure prophylaxis (PrEP) for infants say that it is high time

Published
05 April 2017
By
Gus Cairns
Studies look at brain and cognitive changes in people with HIV as they age

People with HIV often show persistent signs of cognitive impairment and abnormalities in brain structure despite suppressive antiretroviral therapy (ART), but they do not appear to experience

Published
14 March 2017
By
Liz Highleyman
Minority Within A Minority: Women Ageing With HIV

My research is a three year project, exploring what it is like to be an older women with HIV, how the social and physical experiences of ageing are affected by HIV, and what support exists or is needed to enable older women living with HIV to age well.

Published
09 March 2017
From
Huffington Post
← First12345...52Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.